ITGB1 and cancer: According to Fig. 2B, in the following cancer types: ACC, CESC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, PAAD, and STAD (P < 0.05), poor overall survival was linked to higher ITGB1 expression (OS) (Fig. 2B).In addition, disease-free survival (DFS) analysis suggested that ITGB1 upregulation was associated with ACC, CESC, COAD, KICH, LGG, and LUAD, USC, MESO, PAAD, and SARC were significantly associated with poor prognosis (P < 0.05) (Fig. 2C).